Charles Weston
Stock Analyst at RBC Capital
(0.20)
# 4,591
Out of 5,000 analysts
331
Total ratings
37.9%
Success rate
-5.7%
Average return
Main Sectors:
Stocks Rated by Charles Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 900p | 490p | +83.67% | 32 | Sep 22, 2026 | |
| ETR: EVT Evotec SE | Reiterated: Buy | €10.00 | €2.75 | +263.11% | 54 | Aug 13, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Hold | €220.00 | €265.30 | -17.08% | 23 | Aug 12, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €210.00 | €215.80 | -2.69% | 22 | Aug 12, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Reiterated: Buy | €21.00 | €24.25 | -13.40% | 9 | Aug 12, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Reiterated: Hold | €32.00 | €31.54 | +1.46% | 2 | Aug 6, 2026 | |
| LON: SN Smith & Nephew plc | Reiterated: Hold | 1,350p → 1,250p | 1,005p | +24.44% | 2 | Aug 6, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 760.00 | CHF 570.00 | +33.33% | 40 | Aug 3, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 215p → 315p | 212p | +48.87% | 15 | Aug 2, 2026 | |
| SWX: BANB Bachem Holding AG | Reiterated: Buy | CHF 110.00 | CHF 83.05 | +32.45% | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 44.00 | CHF 44.15 | -0.34% | 9 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,600p → 1,400p | 558p | +150.90% | 4 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 225p | 174p | +29.68% | 31 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 108.00 → CHF 96.00 | CHF 74.15 | +29.47% | 16 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,900p | 1,221p | +55.61% | 23 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $67.97 | - | 1 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $287 | $101.90 | n/a | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 310p | 246p | n/a | 20 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 26.00 | CHF 3.40 | n/a | 4 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 287.00 | kr 32.22 | n/a | 2 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 160p | 72p | n/a | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.94 | $0.582 | n/a | 8 | Apr 24, 2018 |
Oxford Biomedica plc
Sep 22, 2026
Reiterated: Buy
Price Target: 900p
Current: 490p
Upside: +83.67%
Evotec SE
Aug 13, 2026
Reiterated: Buy
Price Target: €10.00
Current: €2.75
Upside: +263.11%
Sartorius Aktiengesellschaft
Aug 12, 2026
Reiterated: Hold
Price Target: €220.00
Current: €265.30
Upside: -17.08%
Sartorius Stedim Biotech S.A.
Aug 12, 2026
Reiterated: Buy
Price Target: €210.00
Current: €215.80
Upside: -2.69%
SCHOTT Pharma AG & Co. KGaA
Aug 12, 2026
Reiterated: Buy
Price Target: €21.00
Current: €24.25
Upside: -13.40%
Carl Zeiss Meditec AG
Aug 6, 2026
Reiterated: Hold
Price Target: €32.00
Current: €31.54
Upside: +1.46%
Smith & Nephew plc
Aug 6, 2026
Reiterated: Hold
Price Target: 1,350p → 1,250p
Current: 1,005p
Upside: +24.44%
Lonza Group AG
Aug 3, 2026
Reiterated: Buy
Price Target: CHF 760.00
Current: CHF 570.00
Upside: +33.33%
Convatec Group PLC
Aug 2, 2026
Reiterated: Buy
Price Target: 215p → 315p
Current: 212p
Upside: +48.87%
Bachem Holding AG
Jul 31, 2026
Reiterated: Buy
Price Target: CHF 110.00
Current: CHF 83.05
Upside: +32.45%
Jul 7, 2026
Downgraded: Hold
Price Target: CHF 44.00
Current: CHF 44.15
Upside: -0.34%
Jun 15, 2026
Reiterated: Buy
Price Target: 1,600p → 1,400p
Current: 558p
Upside: +150.90%
May 26, 2026
Reiterated: Buy
Price Target: 225p
Current: 174p
Upside: +29.68%
Mar 16, 2026
Reiterated: Hold
Price Target: CHF 108.00 → CHF 96.00
Current: CHF 74.15
Upside: +29.47%
Mar 4, 2026
Reiterated: Buy
Price Target: 1,900p
Current: 1,221p
Upside: +55.61%
Feb 11, 2026
Upgraded: Buy
Price Target: n/a
Current: $67.97
Upside: -
Jan 7, 2025
Reiterated: Buy
Price Target: $287
Current: $101.90
Upside: n/a
Nov 19, 2024
Reiterated: Buy
Price Target: 310p
Current: 246p
Upside: n/a
Jul 12, 2021
Reiterated: Buy
Price Target: CHF 26.00
Current: CHF 3.40
Upside: n/a
Apr 13, 2021
Reiterated: Buy
Price Target: kr 287.00
Current: kr 32.22
Upside: n/a
Nov 2, 2018
Reiterated: Buy
Price Target: 160p
Current: 72p
Upside: n/a
Apr 24, 2018
Reiterated: Buy
Price Target: $6.94
Current: $0.582
Upside: n/a